XALKORI caps 200 mg 60 pce

7680621310011 CH-62131 L01ED01 07.16.1.

Reimbursement limitations:

XALKORI_alk

Cancer du poumon non à petites cellules (NSCLC) ALK-positif avancé
Après accord de prise en …

XALKORI caps 200 mg 60 pce
XALKORI caps 200 mg 60 pce
XALKORI caps 200 mg 60 pce
1 / 3
google

Details

Product number
6213101
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
crizotinibum 200 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum A corresp. natrium 0.84 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Xalkori 200 mg, Hartkapseln
Kapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/07/2025
Patient information leaflet
Français
23/07/2025
Patient information leaflet
Italien
23/07/2025
Professional SmPC
Allemand
23/07/2025
Professional SmPC
Français
23/07/2025
Professional SmPC
Italien
23/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.84 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 4058.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2013

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
62131
Drug name
Xalkori, Hartkapseln
Galenic form
KAHA
ATC Code
L01ED01
Authorization status
Z
Dispensation category
A
First authorization
05/03/2012
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
XALKORI caps 200 mg 60 pce
Description (DE)
XALKORI Kaps 200 mg 60 Stk
Market launch
05/03/2012
Narcotic (BTM)
No

Other packaging sizes

XALKORI caps 250 mg 60 pce
60 KAP
View